Votre programme de soutien au patient 'Ally' & Design — 1861802

Toolbar

Details

Application number

1861802

Registration number

TMA1061755

Type(s)

Design

Category

Trademark

CIPO Status

REGISTERED

TM5 status

LIVE/REGISTRATION/Issued and Active
The trademark application has been registered with the Office.

Filed

2017-10-10

Registered

2019-11-04

Registration Expiry Date

2029-11-04

Current owner

FINCHLEY RESEARCH & DEVELOPMENT INC.
100-6111 Av Royalmount
Montréal
QUEBEC H4P2T4

Agent

LAVERY, DE BILLY, LLP
1 Place Ville Marie, Suite 4000
Montréal
QUÉBEC H3B4M4

Registered Owner

Pharmascience Inc.
6111 avenue Royalmount Suite 100
Montreal
QUEBEC H4P2T4

Applicant

Pharmascience Inc.
6111 avenue Royalmount Suite 100
Montreal
QUEBEC H4P2T4

Documents

Index headings

  • ALLY VOTRE PROGRAMME DE SOUTIEN AU PATIENT

Vienna information (Code & Description)

1.15.23
Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).
26.2.1
Segments of circles or ellipses (except 26.2.7)
26.2.5
Joined or intersecting segments or sectors of circles or ellipses
26.4.2
Rectangles
A 26.4.5
One quadrilateral
A 26.4.18
Quadrilaterals containing one or more letters
A 26.4.24
Quadrilaterals with dark surfaces or parts of surfaces

Goods (Nice class & Statement)

16
(1) Print materials namely, agendas and enrollment forms for patients and healthcare professionals; educational printed materials namely, newsletters, communication letters, pamphlets, manuals, leaflets, and guides.

Services (Nice class & Statement)

35
(1) Administration of patient support programs; business management of reimbursement assistance and dispensing of pharmaceuticals for physicians, pharmacists and patients; distribution of information on pharmaceutical products relating to multiple sclerosis for use in humans and disease states to health care practitioners and patients; Call centre services for manufacturers and marketers of pharmaceutical products relating to multiple sclerosis and biological products for use in humans to ensure the proper prescribing, business management of reimbursement assistance and dispensing of pharmaceuticals for physicians, pharmacists and patients
36
(2) Assistance in obtaining insurance coverage for medication relating to multiple sclerosis and help ensure adherence and compliance with follow-up calls
38
(3) Access to nurses or other healthcare professionals via phone or online chat to assist in the administration of the healthcare support program, relating to multiple sclerosis, to their patients;
41
(4) Educational services in the field of multiple sclerosis medicine, disease information and resources; access to the online training and seminars to assist in the administration of the healthcare support program, relating to multiple sclerosis, to their patients; distribution of information on pharmaceutical products relating to multiple sclerosis use in humans and disease states to health care practitioners and patients;
44
(5) Medical services and consulting services, namely pharmaceutical products relating to multiple sclerosis; information and consultancy services in the field of medicine relating to multiple sclerosis; nursing and clinical services related to the administration of pharmaceutical products relating to multiple sclerosis to humans; consulting services, namely pharmaceutical consulting relating to multiple sclerosis;

Claims

  • Proposed Use in CANADA

Recordals (known also as Footnotes)


CHANGE IN TITLE / CHANGEMENT EN TITRE:
TYPE OF CHANGE / GENRE DE CHANGEMENT: Assignment / Cession
DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2022-04-27
DATE OF CHANGE / DATE DE CHANGEMENT: 2021-10-01
COMMENTS / COMMENTAIRES: FROM/DE: Pharmascience Inc.
TO/A: FINCHLEY RESEARCH & DEVELOPMENT INC.

Action History

Actions
Action Action date Due date Comments
Filed 2017-10-10
Created 2017-10-11
Formalized 2017-10-11
Rep for Service Changed 2018-04-04 From: To: 4779 / Voir Preuve au dossier/See evidence on File No. 106547
Agent Changed 2018-04-04 From: To: 4779 / Voir Preuve au dossier/See evidence on File No. 106547
Search Recorded 2018-11-22
Examiner's First Report 2018-11-22 2019-05-22
Correspondence Created 2018-12-19 2019-06-19
Approved 2019-06-28
Approval Notice Sent 2019-06-28
Advertised 2019-07-17 Vol.66 Issue 3377
Registration Pending 2019-10-09
Registration Fee Notice Sent 2019-10-09 2020-04-09
Registered 2019-11-04 2029-11-04
Change of Title Registered 2022-04-27 Assignment/Cession
Agent Changed 2025-03-31 From/De: 4779 To/A: 7179
Date modified: